Skip to content
As the U.S. cannabis market continues to grow, the recent weakness in the sector stocks provides a great opportunity for long term gains while still fraught with high risk. The majority of the stocks in the U.S. cannabis sector are down far more than 50% from the highs reached just this year. The multi-state operators (MSOs) have major catalysts with languishing large deals in the late stages of obtaining approval to where these stocks will finally take the next step higher to general market visibility.The U.S. cannabis sector is already massive and growing at a rapid pace. Arcview Market Research has the market reaching $12.8 billion this year and reaching $30.1 billion by 2024. The sector is forecasted to add ~$3 billion in additional revenues each year through 2024.(Source: Curaleaf presentation)The U.S. stocks don’t face the same problems with a lack of stores or product like in Canada, but the companies...
(Bloomberg) -- The deadly pig disease that’s destroying China’s hog herd has sparked a global frenzy around meat supplies and lifted pork prices all over the world -- everywhere, that is, except in the U.S.While that’s good news for American bacon eaters who are still enjoying relatively cheap rashers, it’s troubling for farmers dealing with a glut and thin profit margins. Hedge funds, meanwhile, seem to be losing patience with the U.S. hog market.African swine fever’s rapid spread has killed millions of pigs in China, the world’s top pork producer and consumer. Even as the Asian nation has signaled it’s ready to import record amounts of meat to deal with the supply gap, Chicago hog futures have been basically stagnant for weeks. That’s because bulging American production has minimized the impact of rising exports, which have also been limited by the ongoing U.S.-China trade war.While many analysts expect that supplies will...
Small-cap specialist further trims position in tool manufacturer Continue reading......
Q3 2019 One Group Hospitality Inc Earnings Call...
Q3 2019 Arena Pharmaceuticals Inc Earnings Call...
Q3 2019 Amphastar Pharmaceuticals Inc Earnings Call...
